Industry
MHPA Submits Congressional Testimony on Generic Drug Shortage Legislation
Medicaid Health Plans of America (MHPA) provided testimony to Congress regarding legislative proposals to address drug shortages and ensure access to affordable generic drugs, with particular focus on sterile injectable medications. The trade association representing Medicaid managed care organizations weighed in on pending federal legislation aimed at stabilizing the generic drug supply chain. MHPA's position supports congressional efforts to resolve shortages that affect Medicaid beneficiaries' access to essential medications.
Why it mattersDrug shortages directly impact Medicaid managed care organizations' ability to ensure formulary compliance, manage pharmacy costs, and maintain continuity of care for members requiring sterile injectables and other generic medications.